ENDRA Life Sciences Inc. (Nasdaq: NDRA) ("ENDRA" or the "Company"), a pioneer in thermoacoustic biomarker imaging for early ...

ENDRA Life Sciences Inc (NASDAQ:NDRA) shares are trading lower by some 65% to $0.07 during Tuesday’s session. The company priced a public offering of 61,538,461 shares of common stock (or pre-funded ...

ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of its TAEUS Liver device. The evaluation demonstrated strong intra-operator ...

) has been revised to $38.76 / share. This is a decrease of 17.39% from the prior estimate of $46.92 dated September 27, 2025. The price target is an average of many targets provided by analysts. The ...

As capital rotation intensifies across micro- and small-cap equities in 2026, a new wave of sub-$10 stocks is gaining traction among investors seeking exposure to high-growth themes including ...

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound ...

NDRA is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of NDRA shares has increased $0.84 since the market last closed. This is a ...